医药行业：地方联盟集采机制与规范研究.pdfVIP

地方联盟集采机制与规范研究 I 1 地方联盟集采机制 与规范研究 联合课题组 华中科技大学同济医学院药品政策与管理研究中心 中国外商投资企业协会药品研制和开发工作委员会（RDPAC） 目 录 一、研究背景与研究意义 ······························ 1 （一）研究背景 ························································································ 1 （二）研究意义 ························································································ 1 二、药品地方联盟集采现状 ······························ 2 （一）宏观环境 ························································································ 2 1、政策环境 ············································································································· 2 2、行业条件 ············································································································· 5 3、技术条件 ············································································································· 5 （二）主要药品地方联盟集采实施进展 ··················································· 5 1、广东联盟 ············································································································· 6 2、“八省二区”联盟 ····························································································· 6 3、河南联盟 ············································································································· 6 4、重庆联盟 ············································································································· 6 5、地方联盟集采政策制定面临的主要挑战 ·························································· 7 （三）地方联盟集采与国家组织药品集中带量采购关联 ························· 7 1、地方联盟集采参照国家集采集中带量采购原则 ·············································· 7 2、地方联盟集采与国家集采品种分类开展 ·